Member Info for NathanR999

I don't disagree per se. But I.am.happy to hold as compared to other alternatives playing in the same space for lots of different aspects . Primarily technical solutions and rhe partnerships around that vs just software. Chip based accelerated software routines as DMS develops and partners with forward cameras and high acuity needs for tecakimg viewpoint and functionlising AR overlays and the deep research in human factors that will be homed durther by collaboration in Aerospace. The time to scale has been longer than expected and that has been frustrating for sure. The same has affected all.players in this market. IP has value, my feel for engineering and functional technology is that valeo one stop solution and magna mirror will take a large market share and their teams will do a lot of heavy lifting here. So fundamentaly i am happy to set aside some of the negative aspects.mentioned as i think the other side of the ledger is more important. I.am happy with my choice and if Brockl is happy good for them. Saying bye when some one leaves is polite where i come from.

Bye

Clown.

In one word. Cashflow

Will be squeaky for next 12months. Unlikely any awards this side of Xmas. I guess all.of the players in this space are feeling the same issues on cash management. We have some aspects that will keep us alive vs competition. Cipia and tobii volumes are less than ours and Smarteye. Smarteye struggling at.moment but may have some of their pipeline coming through no doubt. Not even sure kpis will move the needle much.

Happy to hold but the attrition here is gonna be tough

Greater than 2.6million cars likely in the kpi update. So.likely 3mill by Jan on road

Excellent explanation. Just spat my.morning coffee out at that! Lol. That's definitely the reason! Gonna defo sell all my shares now - 0 cars this quarter - we should be worried.

TBH with the state of car market even with high volume programmes on stream I am expecting numbers to be up bit maybe at a lesser rate - the media messaging around oems scaling down workforce is a foreboding worry. Legislation will get us where we need to be but road gonna be bumpy this year with fluctuations on growth rate. But this 'delay' definitely means 0 cars this quarter......

Think they said oct/nov as a joint statement but last years KPIs around this quarter was 8th November. So.maybe next week.

From IC

76. Seeing Machines

Seeing Machines (SEE) keeps finding opportunities to grow. The latest is a $6mn (£4.5mn) deal to buy Asaphus Vision from French car parts maker Valeo.

This is part of a broader collaboration that will see the pair work together to sell Seeing Machines’ driver monitoring systems to more of the carmakers that use Valeo’s parts.

The UK company needs to grow user numbers – in its 19-year history as a publicly listed business, it has only made a pre-tax profit once and it hasn’t generated free cash flow since 2009, according to FactSet.

A $5mn payment due from Caterpillar next year means that even though its current cash burn of $2mn a month is double management’s $1mn target, it still has enough in the bank for the next 12 months, analysts at Peel Hunt said at the end of August.

However, unless it meaningfully grows sales or cuts costs, there is a danger that it could soon be tapping up shareholders once more. Sell. MF

Theirs might not be up to snuff. Oem may say we love your mirrors but not software, would you work with Smarteye. Facing the loss of a mirror one might guess they would say yes?

I wonder if some of these are asaphus? The aquisition by see maybe a get around the magna exclusive mirror deal. May also be aspects of semantics. Magna has camera behind mirror service but camera in housing likely can't be protected ip wise. Interesting. Still think gentex has stuff to say in this space, their software may just help them on design aspects. I still think smarteye accesses this route via gentex working relationship.

Launch do OK in UK but much of Pathology market now is driven by large managed service contracts delivered by the big behemoths of roche, abbott, Siemens etc. They have some great franchises liofichem, vircell do very well. Value of acquisition is tricky. No pure play distribution in UK likely could buy as launch one of larger players so capital access would need support. Maybe a non UK hoping to access.market for first time. I think Coris may go separately bass on geography and being a manufacturer and the IVDR overhead is risky as the new regulations bite. I think avacta would be very lucky to get what they payed back and any earn out extras I think would be a massive problem for the acquirer. Real tricky one. I know the company well and some good peeps there. I did muse to.myself that maybe novacyt might look to spend their remaining cash and then really strip out costs by winding down some overlap in roles, facilities. Would get them out of a hole think and I reckon I could get that combined business rocking bwtfdik.

Not clear any of those are camera Dms imho. All suggest indirect monitoring via steering engagement. Mmm

Launch wouldn't sell them at that price, maybe 35- 40k tops. That's going rate for that type of instrument in UK.

In fact they prob won't sell rather they likely will dona reagent rental. Lots of upfront cost that takes 2 to 3 years to unwind and eats capital so may need some kind of asset financing. Just saying

Why would an infectious disease challenge study CRO have anything related to AVCT. How many shares would you want printed in the placement to buy HVO. Clown

I am not an accountant but r and d heavy tech and life sciences do this as the IP and patents are then an asset as they have a tradable value and can generate income in thier own right via licenses etc. I would expect a good tech company to have a lot of IP that could be an asset otherwise the R and D essentially is burnt cash. Anyone else have a take on that?

Bill of materials and integration costs wil be tightly controlled and pre packed. Asp might be way better than just software. Sorry fat fingers on mobile.....

On further thinking this looks to be Bluecruise/supercruise off the shelf for manufacturers that haven't got this option or wish to off load development costs to a white label.

L2+ needs takeover awareness so will defo need eye tracking. A package from a 1 stop supplier could protect pricepoint for see as the bill or materials

Yep. This has already got awards with asaphus dms (now ours) and likely this platform will likely be exclusively positioned as 1 shop adas/dms etc solution with see/asaphus built in for DMS. Just add camera(s) in the cabin for dms/oms. Valeo amd Magna will get lions share of dms in most markets I believe. We will certainly be heavily involved and likely get that 40/50% market share as both have commitments with SEE that are more ingrained than a pure software sale. Both valeo and magna have serious mobileye business and I think that will read across to our dms. Kpi kpi kpi.

Bit of grumbling re the credit line on Smarteye twitter hashtag. Some critics suggesting cfo and ceo should go. CFO did the redeye autotech meet this am. If you thought MK can't present then we'll ding ding we have a new winner. Wonder if that CFO will last the year/next quarter results. MK fundamentally lies about the smarteye position. PMG is at worst overly optimistic. Valeo Collins and Magna clearly happy to work closely and focus heavily with our products. KPIs KPIs KPIs critical. Aviation wasn't mention on the proactive short, would be nice to hear a short focusing on what's being achieve with Collins. Aviation is auto squared in time to.market and regulatory needs, delays are not uncommon.

Nice little kick to the knackers for Jesper re rumour mongering around the mirror. He definately got his goolies squeezed for the cheap jibe he had to delete in the redeye smarteye q and a. Hopefully this settles the horses a bit.